
Before Shefali Jariwala Death, How India First Heard Of Glutathione In Amazon Prime's Made In Heaven 2
Over the past few years, glutathione has surged in popularity, especially after making a mark in Indian pop culture through the series Made In Heaven 2.
What Is Glutathione?
Dr Anupama Bisaria, a dermatologist based in Noida, explains that glutathione is an antioxidant made from the amino acids glycine, cysteine and glutamic acid. Naturally produced by the liver, it plays a vital role in several bodily functions.
According to WebMD, glutathione helps in tissue repair, protein and chemical production, and supports the immune system. When it comes to skin brightening, liposomal glutathione (L-glutathione) and acetyl glutathione are commonly used.
Dr Bisaria recalls that glutathione was once administered to chemotherapy patients during cancer treatment. Interestingly, one observed side effect was lighter skin -- something that later led to its repurposing as a skin-lightening agent.
Today, glutathione is available in various forms. But according to Dr Bisaria, the most effective ones are sublingual tablets (which dissolve under the tongue) and intravenous infusions (drips or injections).
That said, she makes it clear that neither she nor most dermatologists support its use for skin lightening.
"As professionals, we don't support the notion of lightening one's skin to meet certain beauty standards, it's ethically problematic," she says.
Dr Bisaria also adds that she refrains from recommending or administering IV glutathione. While some clinics do offer it, she warns that results are often inconsistent and, given the high cost, many users end up disappointed.
On top of that, glutathione hasn't been approved by the Central Drugs Standard Control Organisation for skin brightening. It comes with known side effects, including:
Nausea
Vomiting
Abdominal cramps
Diarrhoea
Allergic reactions
And since the compound hasn't been studied extensively, many of its potential side effects remain unknown.
How Made In Heaven Brought Glutathione Into The Spotlight In India
The obsession with fair and youthful-looking skin has long been embedded in Indian society. While glutathione was already known in the West, it wasn't as mainstream in India, until 2023.
That year, the Amazon Prime series Made In Heaven released its second season, and in Episode 1, it introduced Indian audiences to glutathione in a context that sharply critiqued societal beauty norms.
In the episode, bride-to-be Sarina (played by Zayn Marie Khan) prepares to marry Aman, an NRI. Her family and future in-laws openly criticise her skin tone. Under pressure, she secretly undergoes a skin treatment that leads to a facial rash just before her bachelorette. The treatment was glutathione shots - which trigger an allergic reaction.
The show was praised online for shedding light on India's obsession with fairness. However, it also brought glutathione into the limelight. Since then, there's been a surge in glutathione-based supplements, powders, and treatments being promoted for glowing, brightened skin, especially by salons and cosmetic clinics ahead of weddings or major events.
A Booming Market
Let's look at some numbers to understand the sudden demand. By 2024, the glutathione market was valued at USD 13.39 million, almost double its size from just five years ago. That number is projected to jump to USD 243.8 million by 2029.
The Asia-Pacific region, including India, is one of the fastest-growing markets for glutathione, driven by the rising demand in personal care and pharma sectors.
However, while glutathione may be in vogue as a quick fix for bright skin, experts continue to advise caution - both for health reasons and the deeper social standards that drive its demand.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hans India
2 hours ago
- Hans India
'National BioBank' holds promise for personalised healthcare for every Indian: Dr Jitendra Singh
The country holds the promise of a future where every Indian may receive individualised treatment tailored to their genetic makeup, lifestyle and environment, Union Minister of State (Independent Charge) for Science and Technology, Dr Jitendra Singh, said on Sunday. He inaugurated the state-of-the-art Phenome India "National Biobank" at the CSIR-Institute of Genomics and Integrative Biology (IGIB) in the capital. The newly-launched facility marks a significant stride towards building India's own longitudinal health database and enabling personalised treatment regimens in future. The Biobank will serve as the backbone of a nationwide cohort study, collecting comprehensive genomic, lifestyle, and clinical data from 10,000 individuals across India. Drawing inspiration from the UK Biobank model, the Indian version is tailored to capture the country's unique diversity—across geography, ethnicity, and socio-economic backgrounds. Researchers believe the initiative will aid early diagnosis, improve therapeutic targeting, and bolster the fight against complex diseases such as diabetes, cancer, cardiovascular ailments, and rare genetic disorders. Addressing the scientists and researchers at IGIB, Dr Singh said 'This transition to personalised healthcare is no longer theoretical — it is becoming reality, driven by indigenous innovations.' Reflecting on the unique health challenges faced by Indians, he noted the high prevalence of central obesity, a risk factor often underestimated. The minister highlighted past research showing that seemingly lean Indians may carry disproportionate fat around their waist, underlining the need for population-specific health strategies. 'Our conditions are complex and deeply heterogeneous. This is where the Biobank becomes vital—it allows us to decode that complexity,' he said. He emphasised that India's scientific landscape is evolving rapidly, citing recent advances in quantum technology, CRISPR-based genome editing, and the fight against antimicrobial resistance (AMR). 'India is no longer lagging behind — we are among the early adopters, sometimes even ahead,' he said. The Biobank, he added, will complement these efforts by generating the kind of high-resolution data that can power AI-driven diagnostics and gene-guided therapies. Dr Singh also called for deeper collaboration between research institutions, government departments like the Department of Biotechnology, and industry partners, particularly in areas such as AMR and drug development. 'Research must extend beyond the lab — it must find takers in the market and beneficiaries in society,' he noted. Dr N. Kalaiselvi, Director General of CSIR and Secretary, DSIR, commended the launch of the Biobank as a bold step toward India's self-reliance in healthcare data.


India.com
3 hours ago
- India.com
India's population growth rate is slowing down, is COVID the reason or...? State with slowest birth rate is...
India's population growth rate is slowing down, is COVID the reason or…? State with slowest birth rate is… New Delhi: The world's most populous country is India, with an estimated population of 146.39 crore (as of April). On the contrary, the country's total fertility rate has plunged to 1.9, falling below the replacement level of 2.1. During the COVID-19 pandemic, the death rate was higher than normal. But even after the COVID-19 pandemic, the ratio of deaths to births remained high in 2022. Except for Madhya Pradesh and Rajasthan, the ratio of deaths to births has not returned to 2019 levels – the pre-COVID era – in almost every state. For example, in 2022, Goa's deaths were 87 percent of its births – much higher than the 70 percent level recorded in the pre-COVID era in 2019 and even higher than in 2020. Shocking Figures Reported In These States In Tamil Nadu, where the ratio was 74 percent in 2022 (equal to 2020) but above the pre-Covid figure of 67 percent. In the southern state of Kerala's the ratio remains at 74 percent, above 56 percent in 2019. Sikkim, which has the lowest fertility rate among all Indian states, also reported a ratio of 61 percent in 2022, higher than both pre-Covid 2019 and pandemic year 2020. Chandigarh and the Andaman and Nicobar Islands, which witnessed a sharp jump in the year 2021, have not been able to return to earlier levels. Andaman and Nicobar Islands reported a 69 percent death-to-birth ratio in 2022, which is also above 58 percent in 2019. Lower Death-To-Birth Ratio Reported In These States In contrast, states with predominantly young populations, like Bihar, Uttar Pradesh, and Jharkhand, witnessed significantly lower death-to-birth ratios, below 30 percent. Bihar's ratio being less than 15 percent. Uttar Pradesh and Jharkhand reported notable population increases in 2021, although the growth rate showed a slight decrease in 2022.


Time of India
4 hours ago
- Time of India
Union Minister Pralhad Joshi seeks Siddaramaiah's apology after experts ruled out Covid jab caused heart attacks
Union Consumer Affairs & Renewable Energy Minister Pralhad Joshi on Sunday urged chief minister Siddaramaiah to apologise to scientists and researchers for 'insulting' them with his comments that Covid-19 vaccines may have caused heart attack deaths in Hassan district. Pralhad's demand came after an expert panel constituted by the state government into heart attack related deaths in Hassan district ruled out any link between the vaccination and heart attacks. When the pandemic broke out in the country, Prime Minister Narendra Modi acted swiftly and released grants. Siddaramaiah too took the shots of the vaccine in India, not overseas, Joshi told the media in Hubballi. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Depuratore d'acqua di nuova generazione: ecco quanto costa Depuratori d'acqua Scopri di più Undo The PM dealt with the pandemic far more effectively compared to other countries. But Siddaramaiah's statement was offensive to our scientists and questioned the efficacy of Indian vaccines where there was a huge demand for India-made pharma products in the oversea market, he said. Siddaramaiah's comments suggesting Covid-19 vaccination may have caused the recent heart-attack related deaths had triggered a wave of rebuttals from senior doctors, Biocon founder Kiran Mazumdar-Shaw and the BJP. Live Events The All-India Institute of Medical Sciences had dismissed any connection between the two. A study on the people who succumbed to sudden cardiac arrests did not reveal any link to the Covid vaccination, AIIMS experts said.